Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 12065
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675530(US11987556, Compound 5)
Affinity DataIC50: 38nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4C(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675529(US11987556, Compound 4)
Affinity DataIC50: 109nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675526((S)-2-((2-(1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methyls...)
Affinity DataIC50: 178nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675531(US11987556, Compound 6)
Affinity DataIC50: 214nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675528(US11987556, Compound 3)
Affinity DataIC50: 215nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675527(US11987556, Compound 2)
Affinity DataIC50: 308nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675529(US11987556, Compound 4)
Affinity DataIC50: 710nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4C(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675531(US11987556, Compound 6)
Affinity DataIC50: 734nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4C(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675530(US11987556, Compound 5)
Affinity DataIC50: 826nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4C(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675528(US11987556, Compound 3)
Affinity DataIC50: 1.03E+3nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4C(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675526((S)-2-((2-(1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methyls...)
Affinity DataIC50: 2.23E+3nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4C(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675527(US11987556, Compound 2)
Affinity DataIC50: 2.26E+3nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent